SecureAire, SARS-CoV-2 and the COVID-19 Pandemic
The COVID-19 pandemic, which is caused by the SARS-CoV-2 virus, has killed over one million people worldwide, and destroyed many aspects of normal life.
Early in the pandemic it was assumed that transmission occurred via surface contact, carried on clothing, personal contact, and droplet routes. It is now clear that the dominant route of passing this deadly infection is from aerosolized droplets and airborne dried out viral nuclei. These infectious particles can remain suspended for hours or even days.
SARS-CoV-2 has been demonstrated to survive within, and be transported by, a building’s ventilation system. Depending upon indoor air conditions and ventilation system components, it can remain viable and infectious for up to nine days.
Indoor air in general, and especially poorly ventilated spaces, can be threatening to inhabitants due to the extremely small size, survivability, and contagious nature of SARS-CoV-2. Even minimal contact with, or inhalation of the virus, has been shown to cause COVID-19.
Testing an IAQ Product’s Effectiveness on SARS-CoV-2
Numerous Indoor Air Quality (IAQ) technologies have published test results “proving” they quickly and efficiently destroy the SARS-CoV-2. In every case these tests were done in highly controlled and limited environments. In some cases, devices designed to treat large rooms were applied to one cubic foot test chambers. Published science suggests that results from such micro-environments cannot be applied to macro-environments. In other words, you, your family, and your customers should demand test results based on real-world settings that reflect the spaces where you live, work, study, and recreate.
You should expect real-world results documenting the impact of any IAQ technology on ultra-fine particle (< 1 micron) and pathogen removal from the occupied space, reduction in bacterial and viral contamination, and most importantly reduction or elimination of respiratory viral infections. Any technology that meets that testing standard will have to be highly effective in removing, capturing, and destroying/inactivating any aerosolized and airborne bacteria, spores, or virus.
SecureAire Testing and Verification of Performance
In a recently published studies, SecureAire technology underwent real-world testing and met the clinical threshold of reducing actual viral and bacterial infections in an occupied space. No other IAQ technology can make this claim. They include:
Particle Control reduces fine and ultrafine particles greater than HEPA filtration in live operating rooms and kills biologic warfare surrogate, Ereth, et al, American Journal of Infection Control, 2020.
Hospital-wide particle control technology reduces respiratory viral particles and pathogens and reduces bacterial infections in a pediatric long-term post-acute care facility, Fine, et al, Personal Communication, submitted for publication.
SARS-CoV-19 Pathogen Inactivation
The SARS-CoV-2 virus is exponentially easier to destroy than the Anthrax surrogate (Bacillus subtilis) used in the above study published by the American Journal of Infection Control. If Bacillus subtilis can be removed and destroyed (proven by SecureAire technology), then the SARS-CoV-2 virus will certainly be removed and destroyed even more quickly (Personal Communication, Mark T. Hernandez, PhD, Director, Environmental Engineering Microbiology and Disinfection Lab, University of Colorado).
SecureAire Technology is the Only Complete IAQ Solution…
SecureAire is the only technology that will:
- remove airborne particulates, pathogens and VOCs from an occupied space
- capture contaminants on a better-than hospital grade cartridge
- destroy captured living organisms such as bacteria, inactivate viruses, and break down VOCs into harmless elements
- create no harmful byproducts such as ozone, hydroxyl radicals nor others such as formaldehyde
- not restrict airflow and cause compromised heating and cooling system performance.